vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and TRICO BANCSHARES (TCBK). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $109.4M, roughly 1.1× TRICO BANCSHARES ). TRICO BANCSHARES runs the higher net margin — 251.6% vs 3.3%, a 248.3% gap on every dollar of revenue. On growth, TRICO BANCSHARES posted the faster year-over-year revenue change (9.0% vs 4.7%). TRICO BANCSHARES produced more free cash flow last quarter ($127.9M vs $7.6M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs 5.4%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Trico Bancshares is a U.S.-headquartered regional bank holding company operating Tri Counties Bank. It offers a full range of retail and commercial banking services including deposit products, mortgages, small business loans, and wealth management, primarily serving consumers and SMEs in Northern California.
NATR vs TCBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $109.4M |
| Net Profit | $4.1M | $33.6M |
| Gross Margin | 72.5% | — |
| Operating Margin | 4.3% | 42.6% |
| Net Margin | 3.3% | 251.6% |
| Revenue YoY | 4.7% | 9.0% |
| Net Profit YoY | 1379.4% | 15.8% |
| EPS (diluted) | $0.23 | $1.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $109.4M | ||
| Q3 25 | $128.3M | $107.6M | ||
| Q2 25 | $114.8M | $103.6M | ||
| Q1 25 | $113.2M | $98.6M | ||
| Q4 24 | $118.2M | $100.4M | ||
| Q3 24 | $114.6M | $99.1M | ||
| Q2 24 | $110.6M | $97.9M | ||
| Q1 24 | $111.0M | $98.5M |
| Q4 25 | $4.1M | $33.6M | ||
| Q3 25 | $5.3M | $34.0M | ||
| Q2 25 | $5.3M | $27.5M | ||
| Q1 25 | $4.7M | $26.4M | ||
| Q4 24 | $-321.0K | $29.0M | ||
| Q3 24 | $4.3M | $29.1M | ||
| Q2 24 | $1.3M | $29.0M | ||
| Q1 24 | $2.3M | $27.7M |
| Q4 25 | 72.5% | — | ||
| Q3 25 | 73.3% | — | ||
| Q2 25 | 71.7% | — | ||
| Q1 25 | 72.1% | — | ||
| Q4 24 | 72.0% | — | ||
| Q3 24 | 71.3% | — | ||
| Q2 24 | 71.4% | — | ||
| Q1 24 | 71.2% | — |
| Q4 25 | 4.3% | 42.6% | ||
| Q3 25 | 7.0% | 43.2% | ||
| Q2 25 | 3.7% | 36.5% | ||
| Q1 25 | 5.4% | 35.8% | ||
| Q4 24 | 3.8% | 38.7% | ||
| Q3 24 | 4.6% | 39.8% | ||
| Q2 24 | 5.1% | 40.0% | ||
| Q1 24 | 4.2% | 38.3% |
| Q4 25 | 3.3% | 251.6% | ||
| Q3 25 | 4.2% | 31.6% | ||
| Q2 25 | 4.6% | 26.6% | ||
| Q1 25 | 4.2% | 26.7% | ||
| Q4 24 | -0.3% | 221.4% | ||
| Q3 24 | 3.8% | 29.3% | ||
| Q2 24 | 1.2% | 29.7% | ||
| Q1 24 | 2.1% | 28.2% |
| Q4 25 | $0.23 | $1.02 | ||
| Q3 25 | $0.30 | $1.04 | ||
| Q2 25 | $0.28 | $0.84 | ||
| Q1 25 | $0.25 | $0.80 | ||
| Q4 24 | $-0.02 | $0.88 | ||
| Q3 24 | $0.23 | $0.88 | ||
| Q2 24 | $0.07 | $0.87 | ||
| Q1 24 | $0.12 | $0.83 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $157.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $161.6M | $1.3B |
| Total Assets | $261.1M | $9.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $157.0M | ||
| Q3 25 | $95.6M | $298.8M | ||
| Q2 25 | $81.3M | $314.3M | ||
| Q1 25 | $86.5M | $308.3M | ||
| Q4 24 | $84.7M | $145.0M | ||
| Q3 24 | $78.7M | $320.1M | ||
| Q2 24 | $68.7M | $206.6M | ||
| Q1 24 | $77.8M | $82.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $1.3B | ||
| Q3 25 | $166.7M | $1.3B | ||
| Q2 25 | $163.7M | $1.3B | ||
| Q1 25 | $167.1M | $1.3B | ||
| Q4 24 | $161.0M | $1.2B | ||
| Q3 24 | $162.6M | $1.2B | ||
| Q2 24 | $156.4M | $1.2B | ||
| Q1 24 | $159.7M | $1.2B |
| Q4 25 | $261.1M | $9.8B | ||
| Q3 25 | $264.8M | $9.9B | ||
| Q2 25 | $254.9M | $9.9B | ||
| Q1 25 | $252.7M | $9.8B | ||
| Q4 24 | $240.9M | $9.7B | ||
| Q3 24 | $245.3M | $9.8B | ||
| Q2 24 | $235.8M | $9.7B | ||
| Q1 24 | $247.3M | $9.8B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $133.3M |
| Free Cash FlowOCF − Capex | $7.6M | $127.9M |
| FCF MarginFCF / Revenue | 6.1% | 116.9% |
| Capex IntensityCapex / Revenue | 1.9% | 4.9% |
| Cash ConversionOCF / Net Profit | 2.41× | 3.96× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $222.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $133.3M | ||
| Q3 25 | $18.5M | $45.1M | ||
| Q2 25 | $4.3M | $29.2M | ||
| Q1 25 | $2.6M | $24.5M | ||
| Q4 24 | $12.2M | $109.7M | ||
| Q3 24 | $9.6M | $28.6M | ||
| Q2 24 | $1.3M | $31.8M | ||
| Q1 24 | $2.2M | $25.1M |
| Q4 25 | $7.6M | $127.9M | ||
| Q3 25 | $16.8M | $43.2M | ||
| Q2 25 | $3.0M | $28.2M | ||
| Q1 25 | $1.5M | $22.8M | ||
| Q4 24 | $10.0M | $105.2M | ||
| Q3 24 | $7.9M | $27.3M | ||
| Q2 24 | $-2.0M | $30.8M | ||
| Q1 24 | $-1.5M | $24.1M |
| Q4 25 | 6.1% | 116.9% | ||
| Q3 25 | 13.1% | 40.2% | ||
| Q2 25 | 2.6% | 27.2% | ||
| Q1 25 | 1.3% | 23.1% | ||
| Q4 24 | 8.5% | 104.8% | ||
| Q3 24 | 6.9% | 27.6% | ||
| Q2 24 | -1.9% | 31.5% | ||
| Q1 24 | -1.4% | 24.4% |
| Q4 25 | 1.9% | 4.9% | ||
| Q3 25 | 1.3% | 1.7% | ||
| Q2 25 | 1.2% | 1.0% | ||
| Q1 25 | 1.0% | 1.7% | ||
| Q4 24 | 1.9% | 4.5% | ||
| Q3 24 | 1.5% | 1.3% | ||
| Q2 24 | 3.0% | 1.0% | ||
| Q1 24 | 3.3% | 1.0% |
| Q4 25 | 2.41× | 3.96× | ||
| Q3 25 | 3.46× | 1.33× | ||
| Q2 25 | 0.81× | 1.06× | ||
| Q1 25 | 0.55× | 0.93× | ||
| Q4 24 | — | 3.78× | ||
| Q3 24 | 2.21× | 0.98× | ||
| Q2 24 | 0.97× | 1.10× | ||
| Q1 24 | 0.94× | 0.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
TCBK
Segment breakdown not available.
